Wyvratt M - Search Results

1

Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland.

Smith RG, Pong SS, Hickey G, Jacks T, Cheng K, Leonard R, Cohen CJ, Arena JP, Chang CH, Drisko J, Wyvratt M, Fisher M, Nargund R, Patchett A. Smith RG, et al. Among authors: wyvratt m. Recent Prog Horm Res. 1996;51:261-85; discussion 285-6. Recent Prog Horm Res. 1996. PMID: 8701083 Review.

2

Stimulation of growth hormone release from rat primary pituitary cells by L-692,429, a novel non-peptidyl GH secretagogue.

Cheng K, Chan WW, Butler B, Wei L, Schoen WR, Wyvratt MJ Jr, Fisher MH, Smith RG. Cheng K, et al. Among authors: wyvratt mj jr. Endocrinology. 1993 Jun;132(6):2729-31. doi: 10.1210/endo.132.6.8389289. Endocrinology. 1993. PMID: 8389289

3

Peptidomimetic regulation of growth hormone secretion.

Smith RG, Van der Ploeg LH, Howard AD, Feighner SD, Cheng K, Hickey GJ, Wyvratt MJ Jr, Fisher MH, Nargund RP, Patchett AA. Smith RG, et al. Among authors: wyvratt mj jr. Endocr Rev. 1997 Oct;18(5):621-45. doi: 10.1210/edrv.18.5.0316. Endocr Rev. 1997. PMID: 9331545 Review. No abstract available.

4

A potent, orally bioavailable benzazepinone growth hormone secretagogue.

DeVita RJ, Bochis R, Frontier AJ, Kotliar A, Fisher MH, Schoen WR, Wyvratt MJ, Cheng K, Chan WW, Butler B, Jacks TM, Hickey GJ, Schleim KD, Leung K, Chen Z, Chiu SL, Feeney WP, Cunningham PK, Smith RG. DeVita RJ, et al. Among authors: wyvratt mj. J Med Chem. 1998 May 7;41(10):1716-28. doi: 10.1021/jm970816j. J Med Chem. 1998. PMID: 9572898

5

Orally active growth hormone secretagogues.

Patchett AA, Smith RG, Wyvratt MJ. Patchett AA, et al. Among authors: wyvratt mj. Pharm Biotechnol. 1998;11:525-54. doi: 10.1007/0-306-47384-4_23. Pharm Biotechnol. 1998. PMID: 9760695 Review. No abstract available.

6

Acyclic structural variants of growth hormone secretagogue L-692,429.

Lin P, Pisano JM, Schoen WR, Cheng K, Chan WW, Butler BS, Smith RG, Fisher MH, Wyvratt MJ. Lin P, et al. Among authors: wyvratt mj. Bioorg Med Chem Lett. 1999 Nov 15;9(22):3237-42. doi: 10.1016/s0960-894x(99)00568-5. Bioorg Med Chem Lett. 1999. PMID: 10576695

7

Initial structure-activity relationship of a novel class of nonpeptidyl GnRH receptor antagonists: 2-arylindoles.

Chu L, Hutchins JE, Weber AE, Lo JL, Yang YT, Cheng K, Smith RG, Fisher MH, Wyvratt MJ, Goulet MT. Chu L, et al. Among authors: wyvratt mj. Bioorg Med Chem Lett. 2001 Feb 26;11(4):509-13. doi: 10.1016/s0960-894x(00)00707-1. Bioorg Med Chem Lett. 2001. PMID: 11229759

8

SAR studies of novel 5-substituted 2-arylindoles as nonpeptidyl GnRH receptor antagonists.

Chu L, Lo JL, Yang YT, Cheng K, Smith RG, Fisher MH, Wyvratt MJ, Goulet MT. Chu L, et al. Among authors: wyvratt mj. Bioorg Med Chem Lett. 2001 Feb 26;11(4):515-7. doi: 10.1016/s0960-894x(00)00708-3. Bioorg Med Chem Lett. 2001. PMID: 11229760

9

2-(3,5-Dimethylphenyl)tryptamine derivatives that bind to the GnRH receptor.

Lin P, Marino D, Lo JL, Yang YT, Cheng K, Smith RG, Fisher MH, Wyvratt MJ, Goulet MT. Lin P, et al. Among authors: wyvratt mj. Bioorg Med Chem Lett. 2001 Apr 23;11(8):1073-6. doi: 10.1016/s0960-894x(01)00134-2. Bioorg Med Chem Lett. 2001. PMID: 11327593

10

A novel 3-substituted benzazepinone growth hormone secretagogue (L-692,429).

Schoen WR, Pisano JM, Prendergast K, Wyvratt MJ Jr, Fisher MH, Cheng K, Chan WW, Butler B, Smith RG, Ball RG. Schoen WR, et al. Among authors: wyvratt mj jr. J Med Chem. 1994 Apr 1;37(7):897-906. doi: 10.1021/jm00033a006. J Med Chem. 1994. PMID: 8151616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page